Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
02/24/2023* 16:30 EST Earnings Call Q4 2022 -- -- --
02/24/2023* -- Results Q4 2022 -- 1.56 --
11/07/2022 16:30 EST Earnings Call Q3 2022 -- -- --
11/07/2022 -- Results Q3 2022 1.75 1.46 19.59%
08/08/2022 -- Results Q2 2022 1.37 1.66 -17.47%
08/08/2022 16:30 EST Earnings Call Q2 2022 -- -- --
05/09/2022 16:30 EST Earnings Call Q1 2022 -- -- --
05/09/2022 -- Results Q1 2022 1.82 1.78 2.06%
*Estimated Date/Time

Earnings

Next Report Date 02/24/2023 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 11/07/2022
Beat/Miss Upgrade
Return Since 35.48%
Last FQE 09/30/2022
Next FQE 12/30/2022

Profile

Edit
ICU Medical is a California-based, pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. After ICU’s acquisition of Hospira Infusion Systems from Pfizer in 2017, it became one of the largest players in this concentrated industry, holding top-tier positions in its major reporting segments: infusion consumables (37% of 2020 revenue), IV solutions (31%), infusion systems (28%), and critical care (4%). The combined entity remains primarily U.S. focused, generating over 70% of its sales domestically.
URL https://www.icumed.com
Investor Relations URL N/A
HQ State/Province California
Sector Healthcare
Industry Medical Instruments & Supplies
Equity Style Small Cap/Blend
Next Earnings Release Feb. 24, 2023 (est.)
Last Earnings Release Nov. 07, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0.00%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2016
2017
2018
2019
2020
2021
2022
YTD
30.65%
46.59%
6.31%
-18.51%
14.63%
10.65%
-33.65%
22.22%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-18.11%
6.11%
-38.13%
-31.16%
-24.87%
108.1%
-27.93%
-13.82%
-36.28%
21.13%
-78.57%
4.09%
-76.55%
-0.62%
-24.70%
-53.18%
17.86%
3.79%
-47.58%
48.46%
17.10%
-95.00%
-57.48%
77.60%
-68.73%
139.1%
--
--
--
-85.79%
-73.70%
-79.00%
-92.45%
-44.48%
As of January 27, 2023.

Profile

Edit
ICU Medical is a California-based, pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. After ICU’s acquisition of Hospira Infusion Systems from Pfizer in 2017, it became one of the largest players in this concentrated industry, holding top-tier positions in its major reporting segments: infusion consumables (37% of 2020 revenue), IV solutions (31%), infusion systems (28%), and critical care (4%). The combined entity remains primarily U.S. focused, generating over 70% of its sales domestically.
URL https://www.icumed.com
Investor Relations URL N/A
HQ State/Province California
Sector Healthcare
Industry Medical Instruments & Supplies
Equity Style Small Cap/Blend
Next Earnings Release Feb. 24, 2023 (est.)
Last Earnings Release Nov. 07, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
NWGQX 6.646M USD 3.72%
NCAVX 14.36M USD 3.62%
NMAVX 87.55M USD 2.56%
SBRVX 14.73M USD 2.51%
XHE 7.773M USD 1.69%
SMOT 534126.0 USD 1.43%
SUN192 14.14M USD 1.37%
FVUSA04AYS 13.99M USD 0.95%
EWMC 495012.0 USD 0.29%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Nasdaq Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter ICUI Tweets